交易中 06-25 11:13:15 美东时间
+1.955
+1.80%
今日重点评级关注:Jones Trading:维持Definium Therapeutics"买入"评级,目标价从61美元升至74美元;韦德布什:维持Cerebras Systems"跑赢大市"评级,目标价从270美元升至280美元
今天 11:32
今日重点评级关注:Baird:维持Regenxbio"跑赢大市"评级,目标价从27美元升至32美元;古根海姆:维持Tenax Therapeutics"买入"评级,目标价从34美元升至40美元
06-23 13:48
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Roth Capital analyst Leo Mariani upgraded APA Corp (NASDAQ:APA) from Neutral to Buy and raised th...
06-22 20:31
Incyte ( ($INCY) ) has issued an update. Incyte Corporation has reached an agre...
06-22 19:42
BMO Capital analyst Evan Seigerman upgrades Incyte (NASDAQ:INCY) from Underperform to Market Perform and raises the price target from $75 to $94.
06-22 17:22
Incyte Japan wins approval for Minjuvi-lenalidomide in relapsed or refractory DLBCL Incyte won Japan MHLW clearance for Minjuvi (tafasitamab) with lenalidomide in adults with relapsed or refractory DLBCL. Decision targets patients ineligible for autologous stem cell transplant. L-MIND showed 58.8% O
06-19 14:00
Fox Corporation (FOXA) (FOX) struck a deal on Monday to acquire Roku (ROKU) for $160.00 per share. The deal is a combination of cash and Fox stock that values Roku (ROKU) at approximately $22B in ente...
06-15 19:17
因赛特公司(Incyte,股票代码:INCY.O)目前技术面稳定,股价温和上涨0.93%,得益于机构乐观情绪和喜忧参半的资金流向,在消化临床数据更新时展现韧性...
06-15 15:21
Shares of Mirum Pharmaceuticals (MIRM) and Incyte (INCY) are in focus after the companies delivered positive pivotal Phase 2 data for their oral FOP candidate, zilurgisertib. Results from Cohort 1 of ...
06-15 14:38
States across the country are moving ahead with artificial intelligence regulations despite President Donald Trump's efforts to discourage state-level oversight and keep AI policy largely in federal h...
06-14 22:29